Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedJun 23, 2021Ketamine HCl Injection SolutionLabeling: Incorrect Exp. Date: Incorrect BUD.Prisma Health Outsourcing Facility · D-0648-2021Class IITerminatedJun 23, 2021QiYu Hand Sanitizer GelSubpotentWorld Source Llc · D-0632-2021Class IIITerminatedJun 23, 2021Phytonadione Tablets 5 mgFailed Impurities Specification: Out of specification when measuring the impurity degradant D level.AVKARE Inc. · D-0631-2021Class IIITerminatedJun 23, 2021Atorvastatin Calcium TabletsFailed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impuritiesDr. Reddy's Laboratories, Inc. · D-0629-2021Class IIOngoingJun 23, 2021Imperia Elita Vitaccino CoffeeMarketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and FluoxetineDash Xclusive · D-0628-2021Class IIITerminatedJun 16, 2021Levetiracetam Tablets USPLabeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as...McKesson Corporation dba McKesson Drug Company · D-0630-2021Class IIITerminatedJun 16, 2021READYPREP CHGSuperpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.Medline Industries Inc · D-0624-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 1.5% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0610-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 4.25% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0609-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 2.5% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0608-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 1.5% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0607-2021Class IIITerminatedJun 16, 2021DELFELX Peritoneal Dialysis Solution with 4.25% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0606-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 2.5 % DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0605-2021Class IIITerminatedJun 16, 2021DELFLEX Peritoneal Dialysis Solution with 1.5% DextroseTemperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0604-2021Class IITerminatedJun 16, 2021Sodium Chloride 0.9%Temperature Abuse: Product exposed to temperature outside specified limits.Fresenius Medical Care Holdings, Inc. · D-0603-2021Class ITerminatedJun 9, 20211% Lidocaine HCl InjectionLabeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to...Pfizer, Inc · D-0627-2021Class ITerminatedJun 9, 20210.5% Bupivacaine Hydrochloride InjectionLabeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to...Pfizer, Inc · D-0626-2021Class IICompletedJun 9, 2021BusPIRone Hydrochloride TabletsPresence of Foreign Tablets/CapsulesOxford Pharmaceuticals, LLC · D-0602-2021Class IIITerminatedJun 9, 2021Thiamine HCl InjectionLabeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.Mylan Institutional LLC · D-0601-2021Class IITerminatedJun 9, 2021Micardis TabletsSubpotent DrugBoehringer Ingelheim Pharmaceuticals, Inc. · D-0600-2021Class IIITerminatedJun 2, 2021Atorvastatin Calcium TabletsFailed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impuritiesDr. Reddy's Laboratories, Inc. · D-0599-2021Class IITerminatedJun 2, 2021Native Fluoride Toothpaste for Sensitive TeethLabeling: Not Elsewhere Classified; the primary label (tube) may be incorrectly labeled as Fluoride-Free instead of With FluorideAccupac, Inc. · D-0598-2021Class IITerminatedJun 2, 2021Enalapril Maleate TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0597-2021Class IITerminatedJun 2, 2021Brompheniramine MaleateCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0596-2021Class IITerminatedJun 2, 2021CYANOCOBAL Injection 1000MCG/ML 25X1MLCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0595-2021Class IITerminatedJun 2, 2021CorgardCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0594-2021Class IITerminatedJun 2, 2021HALOPERIDOL TABLETS 20mgCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0593-2021Class IITerminatedJun 2, 2021Amantadine Hydrochloride Tablets 100 mgCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0592-2021Class IITerminatedJun 2, 2021BriviactCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0591-2021Class IITerminatedJun 2, 2021VIMPAT (lacosamide) TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0590-2021Class IITerminatedJun 2, 2021VIMPAT(lacosamide) TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0589-2021Class IITerminatedJun 2, 2021INTEGRA 325/40/3mgCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0588-2021Class IITerminatedJun 2, 2021Restora Omega-3 enhanced Lactobacillus Casei KE-99 30 Capsules 1 A Day Nutritional SupplementCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0587-2021Class IITerminatedJun 2, 2021TRAMADOL HYDROCHLORIDE TABLETS USP 100MGCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0586-2021Class IITerminatedJun 2, 2021Folivane-Plus with Ascorbic Acid Precursors Iron/Folic Acid/Vitamin Supplement Capsules 90 CapsulesCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0585-2021Class IITerminatedJun 2, 2021Darifenacin Extended-release Tablets 15 mg 30 TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0584-2021Class IITerminatedJun 2, 2021Darifenacin Extended-release Tablets 7.5 mg 30 TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0583-2021Class IITerminatedJun 2, 2021Sulindac TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0582-2021Class IITerminatedJun 2, 2021Desvenlafaxine Extended-Release Tablets 25 mg 30 TabletsCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0581-2021Class IITerminatedJun 2, 2021Levalbuterol tartrate HFA Inhalation Aerosol 45 mcg/actuation 200 Metered Inhalations Net Contents: 15 gCGMP Deviations: Intermittent exposure to temperature excursion during storage.Cardinal Health Inc. · D-0580-2021